Cholecystectomy
View on Wikipedia| Cholecystectomy | |
|---|---|
A US Navy general surgeon and an operating room nurse performing a laparoscopic cholecystectomy | |
| Pronunciation | /ˌkɒləsɪsˈtɛktəmi/ |
| Specialty | General surgery |
| ICD-9-CM | 575.0 |
| MeSH | D002763 |
| CPT | 47562 |
Cholecystectomy is the surgical removal of the gallbladder. Cholecystectomy is a common treatment of symptomatic gallstones and other gallbladder conditions.[1] In 2011, cholecystectomy was the eighth most common operating room procedure performed in hospitals in the United States.[2] Cholecystectomy can be performed either laparoscopically or through a laparotomy.[3][page needed]
The surgery is usually successful in relieving symptoms, but up to 10 percent of people may continue to experience similar symptoms after cholecystectomy, a condition called postcholecystectomy syndrome.[4] Complications of cholecystectomy include bile duct injury, wound infection, bleeding, vasculobiliary injury, retained gallstones, liver abscess formation and stenosis (narrowing) of the bile duct.[5][4]
Medical use
[edit]
Pain and complications caused by gallstones are the most common reasons for removal of the gallbladder.[6] The gallbladder can also be removed in order to treat biliary dyskinesia or gallbladder cancer.[7]
Gallstones are very common, but 50–80% of people with gallstones are asymptomatic and do not need surgery; their stones are noticed incidentally on imaging tests of the abdomen (such as ultrasound or CT) done for some other reason.[8] The traditional risk factors for gallstones are the four "F's: female, fat, forty, and fertile.[9] Of the more than 20 million people in the US with gallstones, only about 30% will eventually require cholecystectomy to relieve symptoms (pain) or treat complications.[10]
Biliary colic
[edit]Biliary colic, or pain caused by gallstones, occurs when a gallstone temporarily blocks the bile duct that drains the gallbladder.[11] Typically, pain from biliary colic is felt in the right upper part of the abdomen, is moderate to severe, and goes away on its own after a few hours when the stone is either passed or dislodges.[12] Biliary colic usually occurs after meals when the gallbladder contracts to push bile out into the digestive tract. After a first attack of biliary colic, more than 90% of people will have a repeat attack in the next 10 years.[1] Repeated attacks of biliary colic are the most common reason for removing the gallbladder, and lead to about 300,000 cholecystectomies in the US each year.[10][13]
Acute cholecystitis
[edit]Cholecystitis, or inflammation of the gallbladder caused by interruption in the normal flow of bile, is another reason for cholecystectomy.[14] It is the most common complication of gallstones; 90–95% of acute cholecystitis is caused by gallstones blocking drainage of the gallbladder.[15] If the blockage is incomplete and the stone passes quickly, the person experiences biliary colic. If the gallbladder is completely blocked and remains so for a prolonged period, the person develops acute cholecystitis.[16]
Pain in cholecystitis is similar to that of biliary colic, but lasts longer than six hours and occurs together with signs of infection such as fever, chills, or an elevated white blood cell count.[1] People with cholecystitis will also usually have a positive Murphy sign on physical exam – meaning that when a doctor asks the patient to take a deep breath and then pushes down on the upper right side of their abdomen, the patient stops their inhalation due to pain from the pressure on their inflamed gallbladder.[1]
Five to ten percent of acute cholecystitis occurs in people without gallstones, and for this reason, is called acalculous cholecystitis. It usually develops in people who have abnormal bile drainage secondary to a serious illness, such as people with multi-organ failure, serious trauma, recent major surgery, or following a long stay in the intensive care unit.[16]
People with repeat episodes of acute cholecystitis can develop chronic cholecystitis from changes in the normal anatomy of the gallbladder.[16] This can also be an indication for cholecystectomy if the person has ongoing pain.[citation needed]
Cholangitis and gallstone pancreatitis
[edit]Cholangitis and gallstone pancreatitis are rarer and more serious complications from gallstone disease. Both can occur if gallstones leave the gallbladder, pass through the cystic duct, and get stuck in the common bile duct. The common bile duct drains the liver and pancreas, and a blockage there can lead to inflammation and infection in both the pancreas and biliary system. While cholecystectomy is not usually the immediate treatment choice for either of these conditions, it is often recommended to prevent repeat episodes from additional gallstones getting stuck.[14]: 940, 1017
Gallbladder cancer
[edit]Gallbladder cancer (also called carcinoma of the gallbladder) is a rare indication for cholecystectomy. In cases where cancer is suspected, the open technique for cholecystectomy is usually performed.[13]
Liver transplantation
[edit]In living donor liver transplantation between adults, a cholecystectomy is performed in the donor because the gallbladder interferes with removal of the right (lateral) lobe of the liver and to prevent the formation of gallstones in the recipient.[17][18] The gallbladder is not removed in pediatric transplantations as the left lobe of the liver is used instead.[19]
Contraindications
[edit]There are no specific contraindications for cholecystectomy, and in general it is considered a low-risk surgery. However, anyone who cannot tolerate surgery under general anesthesia should not undergo cholecystectomy. People can be split into high and low risk groups using a tool such as the ASA physical status classification system. In this system, people who are ASA categories III, IV, and V are considered high risk for cholecystectomy. Typically this includes very elderly people and people with co-existing illness, such as end-stage liver disease with portal hypertension and whose blood does not clot properly.[7] Alternatives to surgery are briefly mentioned below.
Risks
[edit]All surgery carries risk of serious complications including damage to nearby structures, bleeding, infection,[20] or even death. The operative death rate in cholecystectomy is about 0.1% in people under age 50 and about 0.5% in people over age 50.[10] The greatest risk of death comes from co-existing illness like cardiac or pulmonary disease.[21]
Biliary injury
[edit]A serious complication of cholecystectomy is biliary injury, or damage to the bile ducts.[22] Laparoscopic cholecystectomy has a higher risk of bile duct injury than the open approach, with injury to bile ducts occurring in 0.3% to 0.5% of laparoscopic cases and 0.1% to 0.2% of open cases.[23] In laparoscopic cholecystectomy, approximately 25–30% of biliary injuries are identified during the operation; the rest become apparent in the early post-operative period.[3][page needed]
Damage to the bile ducts is very serious because it causes leakage of bile into the abdomen. Signs and symptoms of a bile leak include abdominal pain, tenderness, fever and signs of sepsis several days following surgery, or through laboratory studies as rising total bilirubin and alkaline phosphatase.[22] Complications from a bile leak can follow a person for years and can lead to death. Bile leak should always be considered in any patient who is not recovering as expected after cholecystectomy.[22] Most bile injuries require repair by a surgeon with special training in biliary reconstruction. If biliary injuries are properly treated and repaired, more than 90% of patients can have a long-term successful recovery.[23]
Injury of the bile ducts can be prevented and treated by routinely using X-ray investigation of the bile ducts (intraoperative cholangiography (IOC)).[24] This method was assessed by the Swedish SBU and routine use deemed to decrease risk of injury and morbidity following unaddressed injury while only increasing cancer rates due to radiation exposure by a lesser fraction.[24]
Other complications
[edit]A review of safety data in laparoscopic cholecystectomy found the following complications to be most common:
| Complication | Prevalence |
|---|---|
| Wound infection | 1.25% |
| Urinary retention | 0.90% |
| Bleeding | 0.79% |
| Retained stone in the common bile duct | 0.50% |
| Respiratory | 0.48% |
| Cardiac | 0.36% |
| Intra-abdominal abscess | 0.34% |
| Hernia | 0.21% |
The same study found the prevalence of bowel injury, sepsis, pancreatitis, and deep vein thrombosis/pulmonary embolism to be around 0.15% each.[25]
Leakage from the stump of the cystic duct is a complication that is more common with the laparoscopic approach than the open approach but is still rare, occurring in less than 1% of procedures; it is treated by drainage followed by insertion of a bile duct stent.[26]
Another complication singular to the laparoscopic procedure is the phenomenon of the "spilled gallstone" which complicates 0.08–0.3% of cases.[27] Here a stone escapes the resected gallbladder into the abdomen where it can become a focus for infection if it is not identified and removed.[28] Some reports exist of spilled stones lying unnoticed for up to 20 years before eventually causing an abscess to form.[29]
Conversion to open cholecystectomy
[edit]Experts agree that many biliary injuries in laparoscopic cases are caused by difficulties seeing and identifying the anatomy clearly. If the surgeon has problems identifying anatomical structures, they might need to convert from laparoscopic to open cholecystectomy.[30]
Peroperative Endoscopic Retrograde Cholangio-Pancreaticography (ERCP)/ Laparo-endoscopic rendezvous (LERV) technique
CBDS are found in 10–15% of patients during cholecystectomy when intraoperative cholangiography (IOC) is routinely performed.[31] [32] There are several strategies to manage choledocholithiasis but the optimal method as well as the timing of treatment is still under debate.[33]
In recent years the LERV technique, in which access to the common bile duct by ERCP is facilitated by an antegrade guidewire, which is intraoperatively introduced during fluoroscopy and is advanced through the cystic duct to the duodenum, has been established as an alternative to treat common bile duct stones discovered during laparoscopic cholecystectomy. This technique was first described in 1993 by Deslandres et al.[34] and has, in several studies, been shown to have a high rate of CBD stones clearance and a reduced number of complications, particularly post-ERCP pancreatitis, in comparison with conventional ERCP.[35] [36] This is probably due to the facilitated access to the common bile duct with a lesser degree of manipulation and trauma to the papilla Vateri. In a study by Swahn et al. the rendezvous method was shown to reduce the risk of PEP from 3.6 to 2.2% compared with conventional biliary cannulation.[37] The success rate of passing the transcystic guidewire into the duodenum has been reported to be over 80%.[38]
Procedure
[edit]

Pre-operative preparation
[edit]Before surgery, a complete blood count and liver function tests are usually obtained.[39] Prophylactic treatment is given to prevent deep vein thrombosis.[39] Use of prophylactic antibiotics is controversial; however, a dose may be given prior to surgery to prevent infection in certain people at high risk.[40][41] Gas may be removed from the stomach with an OG or NG tube.[39] A Foley catheter may be used to empty the patient's bladder.[39]
Laparoscopic cholecystectomy
[edit]Laparoscopic cholecystectomy uses several (usually 4) small incisions in the abdomen to allow the insertion of operating ports, small cylindrical tubes approximately 5 to 10 mm in diameter, through which surgical instruments are placed into the abdominal cavity. The laparoscope, an instrument with a video camera and light source at the end, illuminates the abdominal cavity and sends a magnified image from inside the abdomen to a video screen, giving the surgeon a clear view of the organs and tissues. The cystic duct and cystic artery are identified and dissected, then ligated with clips and cut in order to remove the gallbladder. The gallbladder is then removed through one of the ports.[42]
As of 2008, 90% of cholecystectomies in the United States were done laparoscopically.[43] Laparoscopic surgery is thought to have fewer complications, shorter hospital stay, and quicker recovery than open cholecystectomy.[44]
Single incision
[edit]Single incision laparoscopic surgery (SILS) or laparoendoscopic single site surgery (LESS) is a technique in which a single incision is made through the navel, instead of the 3-4 four small different incisions used in standard laparoscopy. There appears to be a cosmetic benefit over conventional four-hole laparoscopic cholecystectomy, and no advantage in postoperative pain and hospital stay compared with standard laparoscopic procedures.[45] There is no scientific consensus regarding risk for bile duct injury with SILS versus traditional laparoscopic cholecystectomy.[45]
Natural orifice transluminal
[edit]Natural orifice transluminal endoscopic surgery (NOTES) is an experimental technique where the laparoscope is inserted through natural orifices and internal incisions, rather than skin incisions, to access to the abdominal cavity.[46] This offers the potential to eliminate visible scars.[47] Since 2007, cholecystectomy by NOTES has been performed anecdotally via transgastric and transvaginal routes.[46] As of 2009 the risk of gastrointestinal leak, difficulty visualizing the abdominal cavity and other technical limitations limited further adoption of NOTES for cholecystectomy.[47]
Open cholecystectomy
[edit]In open cholecystectomy, a surgical incision of around 8 to 12 cm is made below the edge of the right rib cage and the gallbladder is removed through this large opening, typically using electrocautery.[42] Open cholecystectomy is often done if difficulties arise during a laparoscopic cholecystectomy, for example, the patient has unusual anatomy, the surgeon cannot see well enough through the camera, or the patient is found to have cancer.[42] It can also be done if the patient has severe cholecystitis, emphysematous gallbladder, fistulization of gallbladder and gallstone ileus, cholangitis, cirrhosis or portal hypertension, and blood dyscrasias.[42]
Biopsy
[edit]After removal, the gallbladder should be sent for pathological examination to confirm the diagnosis and look for any incidental cancer. Incidental cancer of the gallbladder is found in approximately 1% of cholecystectomies.[14]: 1019 If cancer is present in the gallbladder, it is usually necessary to re-operate to remove parts of the liver and lymph nodes and test them for additional cancer.[48]
Post-operative management
[edit]After surgery, most patients are admitted to the hospital for routine monitoring. For uncomplicated laparoscopic cholecystectomies, people may be discharged on the day of surgery after adequate control of pain and nausea.[41] Patients who were high-risk, those who required emergency surgery, and/or those undergoing open cholecystectomy usually need to stay in the hospital several days after surgery.[21]
Subtotal Cholecystectomy
[edit]Intra-operative decisions, with patient safety at the forefront, sometimes call for, what is known in surgical education as, "bail-out" procedures. This is usually due to the surgical team making a clinical decision in the operating room to not proceed with the intended cholecystectomy, due to issues such as adherent bowel or colon, inability to properly identify anatomical planes from previously formed scar-tissue. If there is an inability to safely isolate the structures needed to isolate for cholecystectomy (the cystic duct and the cystic artery) for whatever reason (many times patients have part of the small bowel or colon stuck to the gallbladder, which make it dangerous to pull off without making an accidental hole in the small bowel), the surgical team may elect to do a subtotal cholecystectomy; either a fenestrated or reconstituting type.[49] Essentially, only part of the gallbladder is removed and a drain is left in place for several days. Complications include continued output from drain, which may result in the need for ERCP stent placement to stop drainage.
Long-term prognosis
[edit]In 95% of people undergoing cholecystectomy as treatment for simple biliary colic, removing the gallbladder completely resolves their symptoms.[10]
Up to 10% of people who undergo cholecystectomy develop a condition called postcholecystectomy syndrome.[4] Symptoms are typically similar to the pain and discomfort of biliary colic with persistent pain in the upper right abdomen and commonly include gastrointestinal distress (dyspepsia).[4]
Some people following cholecystectomy may develop diarrhea.[7] The cause is unclear, but is presumed to be due to disturbances in the biliary system that speed up enterohepatic recycling of bile salts. The terminal ileum, the portion of the intestine where these salts are normally reabsorbed, becomes overwhelmed, does not absorb everything, and the person develops diarrhea.[7] Most cases resolve within weeks or a few months, though in rare cases the condition can last for years. It can be controlled with medication such as cholestyramine.[medical citation needed]
A systematic review and meta analysis of eighteen studies on the association between cholecystectomy and the risk of development of colorectal cancer concluded that cholecystecomy has no effect on the risk of colorectal cancer overall, but does have a harmful effect on the risk of right-sided colon cancer.[50] A nationwide cohort study in Korea reported a significantly increased total cancer risk, including increased risk of several different specific types of cancer, after cholecystectomy.[51]
Considerations
[edit]Pregnancy
[edit]It is generally safe for pregnant women to undergo laparoscopic cholecystectomy during any trimester of pregnancy.[8] Early elective surgery is recommended for women with symptomatic gallstones to decrease the risk of spontaneous abortion and pre-term delivery.[8] Without cholecystectomy, more than half of such women will have recurrent symptoms during their pregnancy, and nearly one in four will develop a complication, such as acute cholecystitis, that requires urgent surgery.[8] Acute cholecystitis is the second most common cause of acute abdomen in pregnant women after appendectomy.[16]
Porcelain gallbladder
[edit]Porcelain gallbladder (PGB), a condition where the gallbladder wall shows calcification on imaging tests, was previously considered a reason to remove the gallbladder because it was thought that people with this condition had a high risk of developing gallbladder cancer.[1] However, recent studies have shown that there is no strong association between gallbladder cancer and porcelain gallbladder, and that PGB alone is not a strong enough indication for a prophylactic cholecystectomy.[8]
Alternatives to surgery
[edit]There are several alternatives to cholecystectomy for people who do not want surgery, or in whom the benefits of surgery would not outweigh the risks.
Conservative management
[edit]Conservative management for biliary colic involves a "watch and wait" approach—treating symptoms as-needed with oral medications. Experts agree that this is the preferred treatment for people with gallstones but no symptoms.[8] Conservative management may also be appropriate for people with mild biliary colic, as the pain from colic can be managed with pain medications like NSAIDs (ex: ketorolac) or opioids.[1]
Conservative management for acute cholecystitis involves treating the infection without surgery. It is usually only considered in patients at very high risk for surgery or other interventions listed below. It consists of treatment with intravenous antibiotics and fluids.[52]
ERCP
[edit]

ERCP, short for endoscopic retrograde cholangiopancreatography, is an endoscopic procedure that can remove gallstones or prevent blockages by widening parts of the bile duct where gallstones frequently get stuck. ERCP is often used to retrieve stones stuck in the common bile duct in patients with gallstone pancreatitis or cholangitis. In this procedure, an endoscope, or small, long thin tube with a camera on the end, is passed through the mouth and down the esophagus. The doctor advances the camera through the stomach and into the first part of the small intestine to reach the opening of the bile duct. The doctor can inject a special, radiopaque dye through the endoscope into the bile duct to see stones or other blockages on x-ray.[53] ERCP does not require general anaesthesia and can be done outside of the operating room. While ERCP can be used to remove a specific stone that is causing a blockage to allow drainage, it cannot remove all stones in the gallbladder. Thus, it is not considered a definitive treatment and people with recurrent complications from stones will still likely need a cholecystectomy.[citation needed]
Cholecystostomy
[edit]Cholecystostomy is the drainage of the gallbladder via insertion of a small tube through the abdominal wall. This is usually done using guidance from imaging scans to find the right place to insert the tube. Cholecystostomy can be used for people who need immediate drainage of the gallbladder but have a high risk of complications from surgery under general anaesthesia, such as elderly people and those with co-existing illnesses.[52] Draining pus and infected material through the tube reduces inflammation in and around the gallbladder. It can be a lifesaving procedure, without requiring that the person undergo emergency surgery.[54]
The procedure does come with significant risks and complications—in one retrospective study of patients who received percutaneous cholecystostomy for acute cholecystitis, 44% developed choledocholithiasis (one or more stones stuck in the common bile duct), 27% had tube dislodgment, and 23% developed postoperative abscess.[54]
For some people, drainage with cholecystostomy is enough and they do not need to have the gallbladder removed later. For others, percutaneous cholecystostomy allows them to improve enough in the short term that they can get surgery at a later time.[52] There is no clear evidence one way or another to indicate that surgical removal after cholecystostomy is best for high-risk surgical patients with acute cholecystitis.[52]
Frequency of use
[edit]About 600,000 people receive a cholecystectomy in the United States each year.[14]: 855
In a study of Medicaid-covered and uninsured U.S. hospital stays in 2012, cholecystectomy was the most common operating room procedure.[55]
Gallstones affect approximately 10-15% of the global adult population, with the incidence rising with age and more commonly affecting women. As a result, cholecystectomy is one of the most common abdominal surgeries performed worldwide.[56]
History
[edit]
Carl Langenbuch performed the first successful cholecystectomy at the Lazarus hospital in Berlin on July 15, 1882.[57] Before this, surgical therapy for symptomatic gallstones was limited to cholecystostomy, or gallstone removal.[57] Langenbuch's rationale for developing the new technique stemmed from 17th century studies in dogs that demonstrated the gallbladder to be nonessential and medical opinion among his colleagues that gallstones formed in the gallbladder.[57] Although the technique was initially controversial, cholecystectomy became established as a lower mortality procedure than cholecystostomy by the 20th century.[57]
Laparoscopic technique
[edit]Erich Mühe performed the first laparoscopic cholecystectomy on September 12, 1985, in Böblingen, Germany.[58] Mühe was inspired to develop a technique for laparoscopic cholecystectomy by the first laparoscopic appendectomy, performed by gynecologist Kurt Semm in 1980.[59] He subsequently designed an optical laparoscope with a working channel large enough to fit a distended gallbladder.[59] Mühe presented his technique to the Congress of the German Surgical Society in 1986, claiming reduced postoperative pain and shorter hospitalization.[60] His work was met with strong resistance by the German surgical establishment and he had difficulty communicating it in English. It was consequently ignored.[59] Mühe's work was further disparaged in 1987, when he was charged with manslaughter for a postoperative patient death that was mistakenly attributed to his innovative technique.[61] He was exonerated in 1990 after further investigation.[61] His pioneering work was eventually recognized by the German Surgical Society Congress in 1992.[59]
Philippe Mouret performed laparoscopic cholecystectomy on March 17, 1987, in Lyon, France.[59] His technique was rapidly adopted and improved in France.[59] It was subsequently introduced to the rest of the world over the next three years.[59] Driven by popularity among patients, the laparoscopic technique became preferred over open surgery and noninvasive treatments for gallstones.[59]
By 2013, laparoscopic cholecystectomy had replaced open cholecystectomy as the first-choice of treatment for people with uncomplicated gallstones and acute cholecystitis.[42][62]
By 2014 laparoscopic cholecystectomy had become the gold standard for the treatment of symptomatic gallstones.[39][63]
Laparoscopic cholecystectomy can be a challenging procedure and surgeons must be trained with advanced laparoscopic skills to complete the operation with safety and effectiveness.[64]
See also
[edit]References
[edit]- ^ a b c d e f Abraham S, Rivero HG, Erlikh IV, Griffith LF, Kondamudi VK (May 2014). "Surgical and nonsurgical management of gallstones". American Family Physician. 89 (10): 795–802. PMID 24866215.
- ^ "Characteristics of Operating Room Procedures in U.S. Hospitals, 2011 – Statistical Brief #170". www.hcup-us.ahrq.gov. Retrieved 2018-01-24.
- ^ a b Mulholland MW, Lillemoe KD, Doherty GM, Upchurch GR, Alam HB, Pawlik TM (December 2016). Greenfield's surgery: scientific principles & practice (6th ed.). Philadelphia: Wolters Kluwer. ISBN 978-1-4698-9001-2. OCLC 933274207.
- ^ a b c d Jaunoo SS, Mohandas S, Almond LM (2010). "Postcholecystectomy syndrome (PCS)". International Journal of Surgery. 8 (1): 15–7. doi:10.1016/j.ijsu.2009.10.008. PMID 19857610.
- ^ Jadrijevic, S; Sef, D; Kocman, B; Mrzljak, A; Matasic, H; Skegro, D (7 December 2014). "Right hepatectomy due to portal vein thrombosis in vasculobiliary injury following laparoscopic cholecystectomy: a case report". Journal of Medical Case Reports. 8: 412. doi:10.1186/1752-1947-8-412. PMC 4295332. PMID 25481385.
- ^ "The National Institutes of Health (NIH) Consensus Development Program: Gallstones and Laparoscopic Cholecystectomy". consensus.nih.gov. Archived from the original on 2018-03-20. Retrieved 2018-03-20.
- ^ a b c d Townsend CM, Evers BM, Mattox KL, Beauchamp RD (June 2016). Sabiston textbook of surgery: the biological basis of modern surgical practice (20th ed.). Philadelphia, PA: Elsevier Saunders. ISBN 978-0-323-29987-9. OCLC 951748294.
- ^ a b c d e f Agresta F, Campanile FC, Vettoretto N, Silecchia G, Bergamini C, Maida P, Lombari P, Narilli P, Marchi D, Carrara A, Esposito MG, Fiume S, Miranda G, Barlera S, Davoli M (May 2015). "Laparoscopic cholecystectomy: consensus conference-based guidelines". Langenbeck's Archives of Surgery. 400 (4): 429–53. doi:10.1007/s00423-015-1300-4. PMID 25850631. S2CID 19853338.
- ^ Pak, M; Lindseth, G (July 2016). "Risk Factors for Cholelithiasis". Gastroenterology Nursing. 39 (4): 297–309. doi:10.1097/SGA.0000000000000235. PMC 8802735. PMID 27467059.
- ^ a b c d Doherty GM (2015). "Biliary Tract". In Doherty GM (ed.). CURRENT Diagnosis & Treatment: Surgery (14th ed.). McGraw-Hill Education. ISBN 978-0-07-179211-0. OCLC 1328625901.
- ^ "Gallstones". NIDDK. November 2013. Archived from the original on 28 July 2016. Retrieved 27 July 2016.
- ^ Internal Clinical Guidelines Team (UK) (October 2014). Gallstone Disease: Diagnosis and Management of Cholelithiasis, Cholecystitis and Choledocholithiasis. Clinical Guideline 188. National Institute for Health and Care Excellence (NICE). PMID 25473723. NBK258747.
- ^ a b Velasco JM (October 2015). Essential surgical procedures. Philadelphia, PA: Elsevier. ISBN 978-0-323-37567-2. OCLC 949278311.
- ^ a b c d Goldman L (2011). Goldman's Cecil Medicine (24th ed.). Philadelphia: Elsevier Saunders. ISBN 978-1-4377-2788-3.
- ^ Kimura Y, Takada T, Strasberg SM, Pitt HA, Gouma DJ, Garden OJ, Büchler MW, Windsor JA, Mayumi T, Yoshida M, Miura F, Higuchi R, Gabata T, Hata J, Gomi H, Dervenis C, Lau WY, Belli G, Kim MH, Hilvano SC, Yamashita Y (January 2013). "TG13 current terminology, etiology, and epidemiology of acute cholangitis and cholecystitis". Journal of Hepato-Biliary-Pancreatic Sciences. 20 (1): 8–23. doi:10.1007/s00534-012-0564-0. hdl:2292/22434. PMID 23307004.
- ^ a b c d Kimura Y, Takada T, Kawarada Y, Nimura Y, Hirata K, Sekimoto M, Yoshida M, Mayumi T, Wada K, Miura F, Yasuda H, Yamashita Y, Nagino M, Hirota M, Tanaka A, Tsuyuguchi T, Strasberg SM, Gadacz TR (2007). "Definitions, pathophysiology, and epidemiology of acute cholangitis and cholecystitis: Tokyo Guidelines". Journal of Hepato-Biliary-Pancreatic Surgery. 14 (1): 15–26. doi:10.1007/s00534-006-1152-y. PMC 2784509. PMID 17252293.
- ^ "What to expect after your liver transplant | Nebraska Medicine Omaha, NE". www.nebraskamed.com.
- ^ "Living Donor Liver Transplant | Baltimore". www.umms.org.
- ^ "Liver Donors FAQ: The Donation Surgery". ucsfbenioffchildrens.org.
- ^ "Cholecystectomy". Johns Hopkins Medical. 19 November 2019.
- ^ a b "Treatment of Gallstones and Gallbladder Disease". Society for Surgery of the Alimentary Tract. Retrieved 2018-03-27.[dead link]
- ^ a b c Abbasoğlu O, Tekant Y, Alper A, Aydın Ü, Balık A, Bostancı B, Coker A, Doğanay M, Gündoğdu H, Hamaloğlu E, Kapan M, Karademir S, Karayalçın K, Kılıçturgay S, Şare M, Tümer AR, Yağcı G (2016). "Prevention and acute management of biliary injuries during laparoscopic cholecystectomy: Expert consensus statement". Ulusal Cerrahi Dergisi. 32 (4): 300–5. doi:10.5152/UCD.2016.3683. PMC 5245728. PMID 28149133.
- ^ a b Stewart L (April 2014). "Iatrogenic biliary injuries: identification, classification, and management". The Surgical Clinics of North America. 94 (2): 297–310. doi:10.1016/j.suc.2014.01.008. PMID 24679422.
- ^ a b "Intraoperative cholangiography in cholecystectomy". www.sbu.se. Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU). 2018-08-17. Retrieved 2019-09-02.
- ^ a b Pucher PH, Brunt LM, Davies N, Linsk A, Munshi A, Rodriguez HA, Fingerhut A, Fanelli RD, Asbun H, Aggarwal R (March 2018). "Outcome trends and safety measures after 30 years of laparoscopic cholecystectomy: a systematic review and pooled data analysis". Surgical Endoscopy. 32 (5): 2175–83. doi:10.1007/s00464-017-5974-2. PMC 5897463. PMID 29556977.
- ^ Siiki A, Rinta-Kiikka I, Sand J, Laukkarinen J (May 2015). "Biodegradable biliary stent in the endoscopic treatment of cystic duct leak after cholecystectomy: the first case report and review of literature". Journal of Laparoendoscopic & Advanced Surgical Techniques. Part A. 25 (5): 419–22. doi:10.1089/lap.2015.0068. PMID 25853929.
- ^ Schafer M, Suter C, Klaiber C, et al. (Apr 1998). "Spilled gallstones after laparoscopic cholecystectomy. A relevant problem? A retrospective analysis of 10,174 laparoscopic cholecystectomies". Surg Endosc. 12 (4): 291–3. doi:10.1007/s004649900659. PMID 9543518. S2CID 610548.
- ^ Satesh-Kumar T, Saklani A, Vinayagam R, Blackett R (Feb 2004). "Spilled gall stones during laparoscopic cholecystectomy: a review of the literature". Postgrad Med J. 80 (940): 77–9. doi:10.1136/pmj.2003.006023. PMC 1742934. PMID 14970293.
- ^ Nugent L, Chandran P (Feb 2018). "Need brooks no delay. Peritoneo-cutaneous fistula formation secondary to gallstone dropped at laparoscopic cholecystectomy 20 years previously: a case report". Journal of Surgical Case Reports. 2018 (2) rjy013. doi:10.1093/jscr/rjy013. PMC 5811847. PMID 29479416.
- ^ Malik AM, Laghari AA, Talpur AH, Khan A (October 2008). "Iatrogenic biliary injuries during laparoscopic cholecystectomy. A continuing threat". International Journal of Surgery. 6 (5): 392–5. doi:10.1016/j.ijsu.2008.07.005. PMID 18823829.
- ^ Persson G, Enochsson L, Sandblom G (8 August 2017). "Årsrapport för Svenskt Kvalitetsregister för gallstenskirurgi". GallRiks.
- ^ Möller M, Gustafsson U, Rasmussen F, Persson G, Thorell A (October 2014). "Natural course vs interventions to clear common bile duct stones: data from the Swedish Registry for Gallstone Surgery and Endoscopic Retrograde Cholangiopancreatography (GallRiks)". JAMA Surg. 149 (10): 1008–13. doi:10.1001/jamasurg.2014.249. PMID 25133326.
- ^ Rábago LR, Vicente C, Soler F, Delgado M, Moral I, Guerra I, Castro JL, Quintanilla E, Romeo J, Llorente R, Vázquez Echarri J, Martínez-Veiga JL, Gea F (August 2006). "Two-stage treatment with preoperative endoscopic retrograde cholangiopancreatography (ERCP) compared with single-stage treatment with intraoperative ERCP for patients with symptomatic cholelithiasis with possible choledocholithiasis". Endoscopy. 38 (8): 779–86. doi:10.1055/s-2006-944617. PMID 17001567.
- ^ Deslandres E, Gagner M, Pomp A, Rheault M, Leduc R, Clermont R, Gratton J, Bernard EJ (1993). "Intraoperative endoscopic sphincterotomy for common bile duct stones during laparoscopic cholecystectomy". Gastrointest Endosc. 39 (1): 54–8. doi:10.1016/s0016-5107(93)70011-5. PMID 8454146.
- ^ Swahn F, Regnér S, Enochsson L, Lundell L, Permert J, Nilsson M, Thorlacius H, Arnelo U (September 2013). "Endoscopic retrograde cholangiopancreatography with rendezvous cannulation reduces pancreatic injury". World J Gastroenterol. 19 (36): 6026–34. doi:10.3748/wjg.v19.i36.6026. PMC 3785624. PMID 24106403.
- ^ Tzovaras G, Baloyiannis I, Zachari E, Symeonidis D, Zacharoulis D, Kapsoritakis A, Paroutoglou G, Potamianos S (March 2012). "Laparoendoscopic rendezvous versus preoperative ERCP and laparoscopic cholecystectomy for the management of cholecysto-choledocholithiasis: interim analysis of a controlled randomized trial". Ann Surg. 255 (3): 435–9. doi:10.1097/SLA.0b013e3182456ec0. PMID 22261836.
- ^ Swahn F, Nilsson M, Arnelo U, Löhr M, Persson G, Enochsson L (April 2013). "Rendezvous cannulation technique reduces post-ERCP pancreatitis: a prospective nationwide study of 12,718 ERCP procedures". Am J Gastroenterol. 108 (4): 552–9. doi:10.1038/ajg.2012.470. PMID 23419386.
- ^ Tommasi C, Bencini L, Bernini M, Naspetti R, Cavallina G, Manetti R, Talamucci L, Farsi M (May 2013). "Routine use of simultaneous laparoendoscopic approach in patients with confirmed gallbladder and bile duct stones: fit for laparoscopy fit for "rendezvous"". World J Surg. 37 (5): 999–1005. doi:10.1007/s00268-013-1962-4. hdl:11380/1331722. PMID 23430003.
- ^ a b c d e Brunicardi FC, Andersen DK, Dunn DL, Hunter JG, Matthews JB, Pollock RE, Billiar TR (2014). Schwartz's principles of surgery (10th ed.). McGraw-Hill Education. ISBN 978-0-07-179674-3.
- ^ Sanabria A, Dominguez LC, Valdivieso E, Gomez G (December 2010). "Antibiotic prophylaxis for patients undergoing elective laparoscopic cholecystectomy". The Cochrane Database of Systematic Reviews (12) CD005265. doi:10.1002/14651858.CD005265.pub2. hdl:10818/49624. PMC 12278356. PMID 21154360.
- ^ a b Overby DW, Apelgren KN, Richardson W, Fanelli R (October 2010). "SAGES guidelines for the clinical application of laparoscopic biliary tract surgery". Surgical Endoscopy. 24 (10): 2368–86. doi:10.1007/s00464-010-1268-7. PMID 20706739. S2CID 10656813.
- ^ a b c d e Yeo, Charles J. (2018). Shackelford's surgery of the alimentary tract. Yeo, Charles J. (8th ed.). Philadelphia, PA: Elsevier. ISBN 978-0-323-40232-3. OCLC 1003489504.
- ^ Ingraham AM, Cohen ME, Ko CY, Hall BL (August 2010). "A current profile and assessment of north American cholecystectomy: results from the American college of surgeons national surgical quality improvement program". Journal of the American College of Surgeons. 211 (2): 176–86. doi:10.1016/j.jamcollsurg.2010.04.003. PMID 20670855.
- ^ Yamashita Y, Takada T, Kawarada Y, Nimura Y, Hirota M, Miura F, Mayumi T, Yoshida M, Strasberg S, Pitt HA, de Santibanes E, Belghiti J, Büchler MW, Gouma DJ, Fan ST, Hilvano SC, Lau JW, Kim SW, Belli G, Windsor JA, Liau KH, Sachakul V (January 2007). "Surgical treatment of patients with acute cholecystitis: Tokyo Guidelines". Journal of Hepato-Biliary-Pancreatic Surgery. 14 (1): 91–7. doi:10.1007/s00534-006-1161-x. PMC 2784499. PMID 17252302.
- ^ a b Lirici MM, Tierno SM, Ponzano C (October 2016). "Single-incision laparoscopic cholecystectomy: does it work? A systematic review". Surgical Endoscopy. 30 (10): 4389–99. doi:10.1007/s00464-016-4757-5. PMID 26895901. S2CID 5966494.
- ^ a b Gaillard M, Tranchart H, Lainas P, Dagher I (October 2015). "New minimally invasive approaches for cholecystectomy: Review of literature". World Journal of Gastrointestinal Surgery. 7 (10): 243–8. doi:10.4240/wjgs.v7.i10.243. PMC 4621474. PMID 26523212.
- ^ a b Chamberlain RS, Sakpal SV (September 2009). "A comprehensive review of single-incision laparoscopic surgery (SILS) and natural orifice transluminal endoscopic surgery (NOTES) techniques for cholecystectomy". Journal of Gastrointestinal Surgery. 13 (9): 1733–40. doi:10.1007/s11605-009-0902-y. PMID 19412642. S2CID 8037138.
- ^ Kapoor VK (March 2001). "Incidental gallbladder cancer". The American Journal of Gastroenterology. 96 (3): 627–9. doi:10.1111/j.1572-0241.2001.03597.x. PMID 11280526. S2CID 28999270.
- ^ Lunevicius, R (April 2020). "Laparoscopic subtotal cholecystectomy: a classification, which encompasses the variants, technical modalities, and extent of resection of the gallbladder". The Annals of the Royal College of Surgeons of England. 102 (4): 315–7. doi:10.1308/rcsann.2020.0007. PMC 7099162. PMID 32003580.
- ^ Mu L, Li W, Ren W, Hu D, Song Y (June 2023). "The association between cholecystectomy and the risk of colorectal cancer: an updated systematic review and meta-analysis of cohort studies". Transl Cancer Res. 12 (6): 1452–65. doi:10.21037/tcr-22-2049. PMC 10331452. PMID 37434692.
- ^ Choi YJ, Jin EH, Lim JH, Shin CM, Kim N, Han K, Lee DH (May 2022). "Increased Risk of Cancer after Cholecystectomy: A Nationwide Cohort Study in Korea including 123,295 Patients". Gut Liver. 16 (3): 465–473. doi:10.5009/gnl210009. PMC 9099388. PMID 35502586.
- ^ a b c d Gurusamy KS, Rossi M, Davidson BR (August 2013). "Percutaneous cholecystostomy for high-risk surgical patients with acute calculous cholecystitis". The Cochrane Database of Systematic Reviews (8) CD007088. doi:10.1002/14651858.CD007088.pub2. PMID 23939652.
- ^ "ERCP: MedlinePlus Medical Encyclopedia". medlineplus.gov. Retrieved 2018-03-19.
- ^ a b Furtado R, Le Page P, Dunn G, Falk GL (February 2016). "High rate of common bile duct stones and postoperative abscess following percutaneous cholecystostomy". Annals of the Royal College of Surgeons of England. 98 (2): 102–6. doi:10.1308/rcsann.2016.0004. PMC 5210469. PMID 26741665.
- ^ Lopez-Gonzalez L, Pickens GT, Washington R, Weiss AJ (October 2014). "Characteristics of Medicaid and Uninsured Hospitalizations, 2012". HCUP Statistical Brief (183). Rockville, MD: Agency for Healthcare Research and Quality. PMID 25535644.
- ^ Wood, Simon; Lewis, Wyn; Egan, Richard (September 2019). "Optimising Surgical Technique in Laparoscopic Cholecystectomy: a Review of Intraoperative Interventions". Journal of Gastrointestinal Surgery. 23 (9): 1925–1932. doi:10.1007/s11605-019-04296-9. ISSN 1091-255X. PMID 31240555.
- ^ a b c d Jarnagin WR, Belghiti J, Blumgart LH (2012). Blumgart's surgery of the liver, biliary tract, and pancreas (5th ed.). Philadelphia: Elsevier Saunders. p. 6. ISBN 978-1-4557-4606-4.
- ^ Reynolds W (2001). "The first laparoscopic cholecystectomy". JSLS. 5 (1): 89–94. PMC 3015420. PMID 11304004.
- ^ a b c d e f g h Polychronidis A, Laftsidis P, Bounovas A, Simopoulos C (2008). "Twenty years of laparoscopic cholecystectomy: Philippe Mouret--March 17, 1987". JSLS. 12 (1): 109–11. PMC 3016026. PMID 18402752.
- ^ Litynski GS (1998). "Erich Mühe and the rejection of laparoscopic cholecystectomy (1985): a surgeon ahead of his time". JSLS. 2 (4): 341–6. PMC 3015244. PMID 10036125.
- ^ a b Stern V (10 June 2013). "The first Lap Chole in Europe: A 'Criminal' Is Vindicated". General Surgery News. Retrieved 4 October 2017.
- ^ Coccolini F, Catena F, Pisano M, Gheza F, Fagiuoli S, Di Saverio S, Leandro G, Montori G, Ceresoli M, Corbella D, Sartelli M, Sugrue M, Ansaloni L (June 2015). "Open versus laparoscopic cholecystectomy in acute cholecystitis. Systematic review and meta-analysis". International Journal of Surgery. 18: 196–204. doi:10.1016/j.ijsu.2015.04.083. PMID 25958296.
- ^ Agresta, Ferdinando; Campanile, Fabio Cesare; Vettoretto, Nereo (2014). Laparoscopic Cholecystectomy: an Evidence-based Guide. Agresta, Ferdinando, Campanile, Fabio Cesare, Vettoretto, Nereo. Cham [Switzerland]: Springer. ISBN 978-3-319-05407-0. OCLC 880422516.
- ^ Mulita, Francesk; Benetatos, Nikolaos; Maroulis, Ioannis; Germanos, Stylianos (2021-01-18). "Enlarged cystic artery". BMJ Case Reports. 14 (1) e240056. doi:10.1136/bcr-2020-240056. PMC 7816909. PMID 33462065.
Further reading
[edit]- "Operation Brochures for Patients: Cholecystectomy". American College of Surgeons. Archived from the original on 2019-08-01. Retrieved 2018-03-20.
- "Gallbladder removal". NHS. 23 October 2017. Retrieved 4 January 2020.
Cholecystectomy
View on GrokipediaIndications
Biliary colic and symptomatic gallstones
Biliary colic refers to the transient, episodic pain resulting from gallstones temporarily obstructing the cystic duct, leading to gallbladder distension without associated inflammation. This condition typically manifests as acute right upper quadrant or epigastric abdominal pain, often triggered by fatty meals, lasting from 30 minutes to several hours before resolving spontaneously.[8][9] The pathophysiology involves a gallstone impacting the cystic duct, which prompts gallbladder contraction in response to cholecystokinin release during digestion, causing increased intraluminal pressure and distension. This distension stimulates visceral pain fibers carried by the vagus and splanchnic nerves, producing the characteristic colicky pain that radiates to the back or shoulder.[8][10] Diagnosis of biliary colic in the context of symptomatic gallstones relies on a compatible clinical history of recurrent postprandial pain and ultrasonographic confirmation of cholelithiasis, with exclusion of inflammatory complications through normal white blood cell count, absence of fever, and no persistent tenderness on examination. Abdominal ultrasound is the primary imaging modality, demonstrating gallstones within the gallbladder and patency of the biliary tree without dilation or wall thickening.[8][11] Cholecystectomy is the standard elective treatment for symptomatic cholelithiasis presenting as biliary colic, particularly when episodes are recurrent or significantly impair quality of life. The Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) recommends laparoscopic cholecystectomy as a safe and effective intervention for most patients with symptomatic gallstones, aiming to prevent further attacks and potential progression to complications such as acute cholecystitis.[12][8] Patient selection for cholecystectomy emphasizes the frequency and severity of biliary colic episodes, with surgery typically indicated after one or more documented attacks that do not respond to conservative measures like dietary modification. The American College of Gastroenterology supports surgical removal of the gallbladder for individuals with symptomatic gallstones to alleviate recurrent pain and reduce the risk of future biliary events, prioritizing those whose symptoms disrupt daily activities.[13][11]Acute cholecystitis
Acute cholecystitis represents an urgent indication for cholecystectomy, characterized by acute inflammation of the gallbladder typically resulting from gallstone obstruction of the cystic duct, necessitating prompt surgical intervention to prevent complications such as perforation or abscess formation.[14] This condition often progresses from biliary colic if untreated, evolving into a systemic inflammatory response that demands diagnostic confirmation and timely management.[15] Cholecystectomy, preferably laparoscopic, is the definitive treatment, with urgency guided by disease severity to optimize outcomes.[16] The pathophysiology begins with obstruction of the cystic duct by a gallstone, leading to bile stasis, increased intraluminal pressure, and chemical irritation of the gallbladder mucosa from concentrated bile.[14] This stasis promotes bacterial overgrowth, commonly involving Escherichia coli, Klebsiella species, and Enterococcus, which ascend from the duodenum and trigger an inflammatory cascade.[17] The resulting edema and ischemia of the gallbladder wall exacerbate the inflammation, potentially leading to necrosis if unresolved.[18] Clinically, patients present with constant right upper quadrant pain that may radiate to the right shoulder or back, accompanied by fever, nausea, and vomiting.[15] A positive Murphy's sign—pain on palpation of the right upper quadrant during deep inspiration—is a hallmark physical finding, often with abdominal guarding.[14] Laboratory evaluation typically reveals leukocytosis with elevated white blood cell count and C-reactive protein levels, indicating systemic inflammation.[19] Diagnosis relies on imaging, with abdominal ultrasound as the initial modality of choice, demonstrating gallbladder wall thickening greater than 4 mm, pericholecystic fluid, and a positive sonographic Murphy's sign.[14] If ultrasound findings are equivocal, hepatobiliary iminodiacetic acid (HIDA) scintigraphy can confirm cystic duct obstruction by showing non-visualization of the gallbladder.[20] The Tokyo Guidelines provide a standardized framework for diagnosis and severity assessment, requiring one local sign (e.g., Murphy's sign or RUQ mass), one systemic sign (e.g., fever or elevated WBC/CRP), and confirmatory imaging.[20] Severity is classified per the Tokyo Guidelines into mild (Grade I, no organ dysfunction), moderate (Grade II, e.g., palpable tender mass, duration >72 hours, or marked local inflammation), and severe (Grade III, with organ dysfunction such as hypotension or respiratory failure).[21] This grading informs management, with mild cases suitable for early intervention. Surgical timing emphasizes early laparoscopic cholecystectomy within 72 hours of symptom onset for mild and moderate cases, reducing hospital stay, complications, and costs compared to delayed surgery.[16] In severe cases with peritonitis or organ failure, initial conservative management with antibiotics and fluids is prioritized, followed by delayed cholecystectomy once stabilized, per Tokyo Guidelines recommendations.[21]Cholangitis and gallstone pancreatitis
Ascending cholangitis, also known as acute bacterial cholangitis, arises from obstruction of the biliary tract, most commonly by gallstones, leading to bile stasis, bacterial overgrowth in the duodenum, and subsequent retrograde ascension of pathogens into the bile ducts.[22] This process results in suppurative infection and potential sepsis if untreated.[22] The classic clinical presentation, known as Charcot's triad, includes fever, jaundice, and right upper quadrant abdominal pain, occurring in approximately 50-70% of cases.[22] In severe instances, particularly with systemic involvement, Reynolds pentad extends this triad to include hypotension and altered mental status, signaling a higher risk of mortality.[22] Diagnosis of ascending cholangitis relies on the Tokyo Guidelines 2018, which require evidence of at least one criterion from each of three categories: systemic inflammation (e.g., fever >38°C or elevated white blood cell count), cholestasis (e.g., jaundice or elevated bilirubin >2 mg/dL), and imaging findings (e.g., biliary dilatation or evidence of etiology on ultrasound or CT).[23] These criteria achieve high sensitivity (91.6%) and specificity (77.5%) for confirming the condition.[23] Suspected definite diagnosis is made when all three categories are met, while suspected diagnosis occurs with two categories plus confirmation via additional tests like magnetic resonance cholangiopancreatography.[23] Gallstone pancreatitis develops when a gallstone transiently or persistently obstructs the ampulla of Vater, allowing bile reflux into the pancreatic duct and premature activation of pancreatic enzymes, which triggers autodigestion of the pancreas and surrounding tissues.[24] This accounts for 40-70% of acute pancreatitis cases, often presenting with epigastric pain radiating to the back, nausea, and elevated serum amylase or lipase levels exceeding three times the upper limit of normal.[24] Severity assessment commonly employs Ranson's criteria, a scoring system evaluating 11 parameters at admission (e.g., age >55 years, white blood cell count >16,000/μL) and 48 hours later (e.g., hematocrit fall >10%, fluid sequestration >6 L), with scores ≥3 indicating severe disease and mortality risks up to 40%.[25] Management of both ascending cholangitis and gallstone pancreatitis prioritizes biliary decompression via endoscopic retrograde cholangiopancreatography (ERCP) to remove obstructing stones and facilitate drainage, typically within 24-48 hours for severe cases or those with cholangitis.[26] Antibiotics targeting enteric organisms (e.g., gram-negative bacilli) are administered concurrently to control infection.[22] Following initial stabilization and resolution of acute symptoms, cholecystectomy is performed as definitive treatment to prevent gallstone recurrence, ideally as an interval procedure 4-6 weeks later in mild to moderate cases, or during the same admission in select mild gallstone pancreatitis patients.[26] The PONCHO trial demonstrated that same-admission cholecystectomy in mild gallstone pancreatitis reduces the composite rate of recurrent biliary complications (e.g., pancreatitis, cholangitis) from 17% in interval procedures to 2%, effectively lowering readmission risks by over 80% without increasing morbidity.[27] This approach underscores cholecystectomy's role in long-term prevention after ERCP-mediated decompression.[27]Gallbladder cancer and other malignancies
Gallbladder cancer is a rare malignancy, with an incidence of 0.2% to 3% in cholecystectomy specimens.[28] Chronic cholelithiasis represents a major risk factor, present in approximately 85% of affected patients, due to associated chronic inflammation promoting carcinogenesis.[29] Porcelain gallbladder, characterized by intramural calcification, also elevates risk, though its incidence is less than 1% in routine cholecystectomies.[30] The disease is often diagnosed incidentally during surgery for symptomatic gallstones, occurring in 0.3% to 3% of elective cholecystectomies.[28] Staging of gallbladder cancer follows the American Joint Committee on Cancer (AJCC) TNM system, which assesses tumor invasion (T), regional lymph node involvement (N), and distant metastasis (M).[31] The T category delineates depth: T1 tumors are confined to the mucosa (T1a) or muscularis (T1b); T2 involves the perimuscular connective tissue; T3 extends into the liver or peritoneum; and T4 invades major structures like the portal vein or hepatic arteries.[32] N staging indicates metastasis to 1-3 (N1) or 4+ regional nodes (N2), while M1 denotes distant spread.[33] This system guides surgical planning, with incidental findings typically revealing early-stage disease (T1-T2) in over 70% of cases.[34] Cholecystectomy serves as the cornerstone of curative treatment, tailored to stage. For T1a tumors, simple cholecystectomy suffices, offering excellent outcomes without need for further resection.[35] In contrast, T1b and T2 lesions require extended cholecystectomy, incorporating wedge resection of the liver bed (segments IVb and V), regional lymphadenectomy (including porta hepatis and celiac nodes), and potential bile duct reconstruction to achieve R0 margins.[36] Advanced T3-T4 stages may necessitate radical procedures, such as right hepatectomy or pancreatoduodenectomy, though palliative cholecystectomy is considered for unresectable cases to alleviate biliary obstruction.[37] Lymph node dissection is critical across stages, as nodal involvement upstages disease and influences adjuvant decisions.[38] Prognosis varies markedly by stage and resectability, with incidental early detection improving survival. The overall 5-year survival rate is less than 5% for advanced disease, but approaches 100% for T1a incidental tumors treated by simple cholecystectomy.[39] [40] For T2 incidental cases undergoing re-resection, 5-year survival reaches 60-75%, underscoring the benefit of extended surgery.[41] Other malignancies involving the gallbladder are uncommon and typically represent metastases, with primary sites including melanoma and renal cell carcinoma.[42] Isolated metastatic lesions may be managed with cholecystectomy akin to primary gallbladder cancer, potentially extending survival in select cases, though prognosis remains guarded due to systemic disease.[43]Prophylactic removal in liver transplantation
Prophylactic cholecystectomy may be considered in the management of patients with end-stage liver disease and asymptomatic cholelithiasis undergoing orthotopic liver transplantation. These patients often have underlying cirrhosis, in which gallstones are prevalent at rates of 25% to 30%, attributed to factors such as altered bile composition, gallbladder stasis, and portal hypertension.[44][45] While the risk of complications from asymptomatic gallstones is low (annual rate <2%), some centers perform cholecystectomy concurrently with transplantation to potentially avert postoperative biliary issues, particularly in the context of immunosuppression. However, reviews indicate no strong evidence supporting routine prophylactic removal in cirrhotic patients, and practice varies by transplant center.[46] The procedure, when performed, is timed to occur simultaneously with the liver transplantation, integrating the cholecystectomy into the hepatectomy phase without necessitating a separate operation. This approach may minimize additional perioperative risks in fragile cirrhotic patients.[47] By excising the gallbladder along with the native liver, potential complications from retained stones or sludge are addressed during the critical posttransplant recovery. During the open orthotopic liver transplantation, the cholecystectomy is performed as part of the recipient hepatectomy, involving careful dissection to remove the gallbladder attached to the explanted liver while preserving vascular and biliary structures of the donor graft. Laparoscopic techniques are rarely used due to the extensive nature of the transplant surgery, with emphasis on avoiding injury to the common bile duct to safeguard graft function.[48] Similarly, the donor graft undergoes routine cholecystectomy prior to implantation to prevent bile leaks from the cystic duct remnant, a common biliary issue with reported incidences of 2% to 25% if overlooked.[49] A study of liver transplant candidates reported cholecystitis in approximately 34% while awaiting transplantation (5.2% acute, 28.9% chronic), highlighting the potential for biliary complications in this population.[50] Although not mandated by major guidelines due to surgical risks in cirrhosis, concurrent removal during transplantation is practiced at some centers to mitigate these risks without added morbidity. In rare instances, gallbladder cancer may be incidentally discovered during the procedure, prompting oncologic staging alongside the transplant evaluation.Preoperative Considerations
Contraindications
Cholecystectomy, whether laparoscopic or open, carries absolute contraindications that preclude surgery due to excessive risk of life-threatening complications. These include uncorrectable coagulopathy, such as an international normalized ratio (INR) greater than 1.5 that cannot be safely reversed, and severe cardiopulmonary instability that prevents tolerance of general anesthesia.[51][52] Relative contraindications involve conditions where surgery may proceed after careful risk-benefit assessment, but with heightened caution or potential need for alternative approaches. Advanced liver cirrhosis, particularly Child-Pugh class C, increases perioperative mortality and is considered a relative contraindication due to risks of bleeding, ascites, and hepatic decompensation.[53] Morbid obesity can limit laparoscopic access and visualization, posing technical challenges, though it does not universally preclude the procedure.[11] Pregnancy is a relative contraindication, but laparoscopic cholecystectomy can be performed safely during any trimester if benefits outweigh risks, with the second trimester preferred due to lower fetal risks from anesthesia and positioning.[54] Preoperative evaluation for contraindications emphasizes a multidisciplinary risk-benefit assessment, including the American Society of Anesthesiologists (ASA) physical status classification, where ASA class IV or V indicates high surgical risk and may favor nonsurgical options.[55] Imaging, such as preoperative ultrasonography or magnetic resonance cholangiopancreatography, is essential to identify anatomical variants like a short cystic duct, which can complicate dissection and increase bile duct injury risk.[51] When contraindications render cholecystectomy inadvisable, alternatives such as percutaneous cholecystostomy provide gallbladder drainage for conditions like acute cholecystitis in high-risk patients, offering a bridge to potential delayed surgery or definitive palliation.[56]Patient preparation and evaluation
Patient preparation for cholecystectomy begins with a thorough history and physical examination to assess symptoms and comorbidities. The history should evaluate for right upper quadrant abdominal pain, postprandial nausea or vomiting, fever, jaundice, and prior episodes of biliary colic, while identifying risk factors such as obesity, diabetes, cardiovascular disease, or previous abdominal surgeries that may influence surgical approach or perioperative risks.[2] Physical examination focuses on signs of acute inflammation, including Murphy's sign (pain on palpation of the right upper quadrant during inspiration), abdominal tenderness, guarding, or distension, alongside a general assessment of nutritional status and overall fitness for surgery.[2] Comorbidities like coagulopathy or uncorrectable bleeding disorders identified here may lead to contraindications, though most patients proceed if optimized.[2] Laboratory evaluation is essential to confirm diagnosis, assess for complications, and guide perioperative management. Routine tests include complete blood count (CBC) to detect leukocytosis suggestive of infection, liver function tests (LFTs) including bilirubin, alkaline phosphatase, and transaminases to evaluate biliary obstruction, and coagulation studies (PT/INR, PTT) to identify bleeding risks.[2] If gallstone pancreatitis is suspected based on history, serum amylase and lipase levels should be measured to confirm pancreatic involvement.[2] Additional tests, such as electrolytes and renal function, are tailored to patient comorbidities for overall risk assessment.[57] Imaging plays a central role in preoperative evaluation to visualize gallstones, assess gallbladder inflammation, and detect bile duct abnormalities. Abdominal ultrasound is the first-line modality, offering high sensitivity for detecting gallstones, gallbladder wall thickening, pericholecystic fluid, and common bile duct dilation.[2] For suspected choledocholithiasis or complex anatomy, magnetic resonance cholangiopancreatography (MRCP) provides non-invasive detailed imaging of the biliary tree.[2] In cases of acute complications like perforation or abscess, computed tomography (CT) may be used for further characterization.[2] Hepatobiliary iminodiacetic acid (HIDA) scan can evaluate gallbladder ejection fraction if biliary dyskinesia is considered.[2] Risk stratification helps predict perioperative mortality and morbidity, guiding optimization and consent discussions. The American Society of Anesthesiologists (ASA) physical status classification is widely used to categorize patients based on comorbidities, with higher ASA scores (III-V) indicating increased risk in cholecystectomy candidates.[58] The Physiological and Operative Severity Score for the Enumeration of Mortality and Morbidity (POSSUM) or its variants like Portsmouth POSSUM provide more detailed predictions, particularly for elderly patients or those with acute cholecystitis, by incorporating physiological parameters and operative factors.[59] These tools aid in identifying high-risk patients who may require multidisciplinary input or alternative management.[60] Preoperative optimization focuses on reducing complications through targeted interventions and informed consent. Fasting for at least 6-8 hours preoperatively is standard to minimize aspiration risk, with adjustments for medications like antiemetics or antihypertensives.[1] Antibiotic prophylaxis is recommended for high-risk cases such as acute cholecystitis (e.g., cefazolin), but not routinely for elective uncomplicated laparoscopic cholecystectomy per Surgical Infection Society guidelines.[61] Venous thromboembolism (VTE) prophylaxis typically involves mechanical methods like sequential compression devices for low-risk laparoscopic procedures, with pharmacologic agents (e.g., low-molecular-weight heparin) reserved for patients with additional VTE risks, as routine use shows no significant benefit.[62] Informed consent must detail the planned laparoscopic approach, potential conversion to open surgery (occurring in 1-5% of cases), and alternatives like watchful waiting for asymptomatic stones, ensuring patients understand risks such as bile duct injury or infection.[63] In the United States, patients seeking surgeons specializing in laparoscopic cholecystectomy (minimally invasive gallbladder removal) can utilize the following resources to locate qualified specialists:- Use Healthgrades to search nationally by procedure ("Laparoscopic Gallbladder Removal (Cholecystectomy)") and location; filter by ratings, experience, hospital quality, and distance.[64]
- Search Castle Connolly's directory by expertise in "Laparoscopic Cholecystectomy" to find top-rated specialists.[65]
- Use the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) "Find a Surgeon" tool to locate members experienced in minimally invasive GI procedures.[66]
- Check US News & World Report for doctors treating gallbladder removal by city or region.[67]
- Ask your primary care physician for referrals to board-certified general surgeons with high procedure volume; verify credentials, experience, and hospital outcomes.
Procedure
Preoperative preparation
Preoperative preparation for cholecystectomy involves several immediate steps in the operating room to ensure patient safety and optimal surgical conditions, building on the foundational assessment from patient preparation and evaluation. General endotracheal anesthesia is the standard approach, providing controlled ventilation and muscle relaxation necessary for establishing pneumoperitoneum.[68] Muscle relaxants are administered to facilitate abdominal insufflation and maintain intra-abdominal pressure without excessive respiratory compromise.[69] The patient is positioned supine on the operating table, then tilted into reverse Trendelenburg with the head elevated 15-30 degrees and a slight left lateral tilt (right side up) to improve access to the right upper quadrant and displace the intestines inferiorly.[2] This positioning enhances visualization of the gallbladder while minimizing pressure on the shoulders and neck, with padding used to prevent nerve injuries such as brachial plexus compression.[12] Prophylactic measures include intravenous antibiotic administration to reduce surgical site infection risk, typically cefazolin 2 g (adjusted for weight) within 60 minutes before incision, particularly for procedures involving the biliary tract. Pneumoperitoneum is then created using carbon dioxide insufflation to an intra-abdominal pressure of 12-15 mmHg, allowing adequate working space while monitoring for hemodynamic effects like increased peak airway pressure.[70] Port placement is planned for the standard four-trocar technique in laparoscopic cholecystectomy: a 10-12 mm umbilical trocar for the camera, a 10 mm epigastric trocar for the surgeon's right hand, a 5 mm right mid-clavicular line trocar for retraction, and a 5 mm anterior axillary line trocar for the left hand or assistance.[71] This configuration optimizes instrument triangulation and ergonomics for the operating team. Informed consent is reviewed immediately prior to induction, emphasizing the risk of conversion from laparoscopic to open cholecystectomy, which occurs in approximately 5-10% of cases, often due to adhesions, inflammation, or unclear anatomy.[72]Laparoscopic cholecystectomy
Laparoscopic cholecystectomy is the preferred minimally invasive approach for gallbladder removal in most patients with symptomatic gallstones or other indications, involving four to five small incisions (typically 5-10 mm) in the abdomen to access and excise the gallbladder.[1] The procedure begins with the patient under general anesthesia in a supine position, tilted to reverse Trendelenburg with left side down to facilitate exposure. Pneumoperitoneum is established by insufflating carbon dioxide gas to create intra-abdominal pressure of 12-15 mmHg, usually via a Veress needle inserted at the umbilicus or through an open Hasson technique to minimize vascular injury risk.[71] In the laparoscopic approach, the standard technique involves four small ports (trocars): typically one at the umbilicus for the camera (10 mm), one epigastric (10 mm) for dissection, and two in the right upper quadrant (5 mm each) for retraction of the gallbladder fundus and liver to expose Calot's triangle. This four-port method is widely used and provides excellent visualization, especially in complex cases such as acute cholecystitis, adhesions, or inflammation. An alternative reduced-port technique uses three ports, omitting the lateral retraction port. Retraction is achieved using the existing ports or adjusted positioning. Studies have shown the three-port method to be safe and feasible in many elective cases, with benefits including less postoperative port-site pain, fewer surgical scars, potentially shorter operative time in experienced hands, and comparable clinical outcomes (e.g., no increased risk of bile duct injury). However, in difficult cases (e.g., thick-walled gallbladder, acute infection, or poor visualization), surgeons may add a fourth port for safety. Both approaches have similar success rates, complication profiles, and recovery when performed by experienced surgeons. Initial abdominal exploration via the 30-degree laparoscope confirms no unexpected pathology, such as adhesions or tumors. The surgeon grasps the gallbladder fundus with a Maryland grasper inserted through the right upper quadrant port and retracts it superiorly and cephalad, while an assistant retracts Hartmann's pouch laterally and inferiorly to open Calot's triangle (the space bounded by the cystic duct, common hepatic duct, and inferior liver edge). Dissection proceeds in Calot's triangle using a hook cautery or Maryland dissector to clear fat and fibrous tissue, achieving the critical view of safety (CVS)—a standardized method to prevent bile duct injury by confirming only the cystic duct and artery enter the hepatobiliary triangle. The CVS requires three criteria: complete clearance of the hepatocystic triangle of all fat and fibrous tissue, separation of the lower one-third of the gallbladder from the liver bed to expose the fossa, and identification of only two structures (cystic duct and artery) entering the dissected triangle, with the cystic plate divided to visualize the common bile duct.[73][2] Once CVS is confirmed, the cystic artery and duct are skeletonized, clipped proximally and distally with a laparoscopic clip applier (using two clips on the proximal side and one distally for each structure), and divided with scissors, taking care to avoid clips on the common bile duct. The gallbladder is then detached from the liver bed using electrocautery or a harmonic scalpel to control small vessels and bile ducts in the fossa, starting from the fundus downward. The specimen is extracted through the umbilical port using an endobag to prevent port-site contamination, followed by port-site closure with absorbable sutures or staples. The procedure typically lasts 30-90 minutes, allowing for same-day discharge in uncomplicated cases and reducing postoperative pain compared to open surgery.[1][2] Key equipment includes a 30-degree laparoscope with video monitor for visualization, atraumatic graspers (e.g., Maryland for dissection), a clip applier for hemostasis and ligation, suction-irrigation system, and insufflator for pneumoperitoneum maintenance.[12] Advantages encompass shorter hospital stays (often 0-1 day versus 3-5 days for open procedures), lower infection rates, and faster return to normal activities (typically 1 week).[71][1] Modifications such as single-incision laparoscopic cholecystectomy (using one umbilical incision for all trocars) or robotic assistance (with enhanced 3D visualization and articulated instruments) may be employed for select patients to further minimize scarring or improve precision, though they require specialized equipment and longer operative times.[71] If visualization is obscured or anatomy is distorted, conversion to open cholecystectomy via a larger incision may be necessary in approximately 5-10% of cases.[72]Open cholecystectomy
Open cholecystectomy is the traditional surgical method for gallbladder removal, involving a larger abdominal incision to provide direct access to the biliary structures, and it is typically reserved for cases where the laparoscopic approach is contraindicated or has failed.[74] This procedure is indicated in patients with prior upper abdominal surgeries leading to extensive adhesions, suspected gallbladder cancer requiring oncologic principles such as en bloc resection, or severe acute inflammation that obscures anatomical landmarks and increases the risk of injury during minimally invasive techniques.[12][75][72] The technique begins with the patient under general anesthesia, positioned supine, and prepped for abdominal access. A right subcostal (Kocher) incision or upper midline laparotomy is made, extending from the midline to the midclavicular line, allowing retraction of the liver to expose the gallbladder and hepatoduodenal ligament.[76] The hepatoduodenal ligament is dissected to visualize Calot's triangle, defined by the cystic duct, common hepatic duct, and inferior liver edge, where the cystic artery and duct are identified, clipped, and divided after achieving the critical view of safety to minimize bile duct injury risk.[77] The gallbladder is then mobilized from its fossa using electrocautery or sharp dissection, detached from the liver bed, and removed through the incision; intraoperative cholangiography may be performed via the cystic duct stump if common bile duct stones are suspected or anatomy is unclear.[76][78] The procedure typically lasts 60 to 120 minutes, depending on complexity such as adhesions or inflammation.[79] Compared to the preferred laparoscopic cholecystectomy, open surgery is associated with longer hospital stays of 3 to 5 days and a higher risk of wound infections, ranging from 5% to 10%.[1][80] Conversion from laparoscopic to open cholecystectomy occurs in approximately 5-10% of cases, most commonly due to intraoperative bleeding obscuring the field, dense adhesions from prior surgeries or chronic inflammation, or unclear anatomy preventing safe dissection of Calot's triangle.[81][72][82] Wound closure is performed in layers: the peritoneum and posterior rectus sheath are approximated with absorbable sutures, followed by the anterior rectus sheath with non-absorbable material, and the skin with staples or subcuticular sutures.[77] Drains, such as a Jackson-Pratt or Penrose, may be placed in the subhepatic space if a bile leak is suspected, particularly in cases of difficult dissection or known inflammation, to manage potential collections.[83][84]Subtotal cholecystectomy
Subtotal cholecystectomy serves as a bailout surgical technique employed during cholecystectomy when dissection of Calot's triangle is deemed unsafe due to obscured anatomy, prioritizing patient safety over complete gallbladder removal to minimize the risk of major biliary injury.[85] This approach is particularly indicated in cases of severe inflammation or acute cholecystitis, extensive pericholecystic fibrosis, and portal hypertension complicating visualization of critical structures such as the cystic duct and common bile duct.[86][87] By avoiding aggressive dissection in hostile conditions, it reduces the potential for iatrogenic damage while still addressing the primary pathology.[88] The procedure encompasses two primary variants: reconstituting subtotal cholecystectomy and fenestrating subtotal cholecystectomy. In the reconstituting type, the anterior and lateral walls of the gallbladder are resected, leaving the posterior wall intact and closed, typically with sutures or staples, and a drain may be placed to manage potential fluid collections.[89] Conversely, the fenestrating type involves resecting the anterior wall while leaving the posterior wall open as a fenestration to facilitate drainage of bile or residual debris directly into the peritoneal cavity, often without closure of the cystic duct stump.[90][91] The choice between these depends on intraoperative findings, such as the extent of inflammation and the presence of stones in the remnant. Surgical technique begins with standard laparoscopic access and initial attempts to achieve the critical view of safety; if unsuccessful, the surgeon proceeds to partial gallbladder dissection, removing the bulk of the organ while preserving the posterior wall adherent to the liver bed. The cystic duct remnant is identified and securely clipped as close as possible to its junction with the common bile duct to prevent leaks, without further mobilization of the hepatobiliary triangle.[92][93] Hemostasis is ensured, and a drain is commonly inserted in the gallbladder fossa for both types to monitor and control postoperative drainage. This method can be completed laparoscopically in approximately 70% of bailout scenarios, avoiding conversion to open surgery.[88] Outcomes of subtotal cholecystectomy demonstrate its efficacy as a safer alternative in difficult cases, with bile leak rates ranging from 10% to 20%, primarily from the cystic duct stump or remnant, compared to higher risks of severe biliary injury (up to 30% in some series) if total cholecystectomy is forcefully pursued.[92][94] Fenestrating procedures may exhibit slightly higher leak incidences due to the open remnant, while reconstituting variants are associated with increased rates of retained stones requiring later intervention, though overall morbidity remains low with readmission rates around 18%.[95] Long-term follow-up indicates acceptable symptom resolution in most patients, with reoperation needed in fewer than 5% for recurrent issues.[95] The Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) explicitly endorses subtotal cholecystectomy within its Safe Cholecystectomy Program as a recommended bailout strategy for situations where the critical view cannot be safely obtained, supported by multi-society guidelines emphasizing its role in reducing bile duct injury rates to below 0.5% in high-risk scenarios.[92] This endorsement is backed by systematic reviews and cohort studies highlighting its favorable risk-benefit profile over alternative approaches in inflamed or cirrhotic livers.[88][85]Complications
Biliary injury
Biliary injury during cholecystectomy, particularly involving the extrahepatic bile ducts, represents one of the most serious intraoperative complications, potentially leading to bile leakage, peritonitis, or long-term strictures if not addressed promptly. The incidence of major bile duct injuries (BDIs) in laparoscopic cholecystectomy is approximately 0.3-0.5%, compared to 0.1-0.2% in open procedures, with rates escalating to 1-2% in cases of acute cholecystitis due to distorted anatomy and inflammation.[96][97] These injuries often result from misidentification of ductal structures during dissection of Calot's triangle, exacerbated by factors such as obesity, previous abdominal surgery, or bleeding. The Strasberg classification system provides a standardized anatomical framework for categorizing BDIs based on the mechanism, location, and extent of damage, guiding subsequent management. Type A injuries consist of bile leaks from the cystic duct stump or accessory ducts (e.g., ducts of Luschka) without disruption of the main biliary tree. Type D injuries involve sectorial or lateral damage to the extrahepatic bile duct, often partial and amenable to localized repair. Type E injuries denote major lacerations or complete circumferential transections of the common hepatic or bile duct, further subdivided by proximity to the confluence (E1-E4), representing the most severe forms with high morbidity.[98][99] Recognition of biliary injuries can occur intraoperatively or postoperatively, with timely detection critical to minimizing sequelae. Intraoperative signs include unexplained bile leakage from the operative field, sudden hypotension indicative of bile peritonitis, or aberrant cholangiographic findings if imaging is performed. Postoperative presentation typically manifests within days to weeks as jaundice, fever, abdominal pain, or external biliary fistula; diagnostic imaging such as ultrasound, CT, or MRCP may reveal bilomas, free fluid, or ductal dilation, while ERCP or PTC confirms the injury site. Approximately 25-30% of BDIs are identified during surgery, 40-50% in the early postoperative period, and the remainder delayed.[100][101] Management of BDIs depends on the injury type, timing of recognition, and surgeon expertise, emphasizing multidisciplinary referral for optimal outcomes. Minor type A or small type D injuries recognized intraoperatively may undergo immediate primary suture repair with or without T-tube drainage, provided there is no significant tissue loss or ischemia. For complex type D or E injuries, conversion to open surgery if laparoscopic, wide drainage, and urgent transfer to a hepatobiliary specialist are recommended; definitive repair often involves Roux-en-Y hepaticojejunostomy, a biliary-enteric anastomosis that bypasses the damaged duct, with success rates exceeding 90% in experienced centers. Endoscopic or percutaneous interventions like stenting are adjuncts for leaks but not substitutes for surgical reconstruction in major transections.[102][98] Prevention remains paramount, centered on meticulous surgical technique and adjunctive tools to enhance anatomical clarity. The critical view of safety (CVS), endorsed by multiple surgical societies, requires complete dissection of the hepatocystic triangle to visualize only two structures entering the gallbladder (cystic duct and artery) before division, reducing misidentification risk by up to 80% in adherent cases. Intraoperative cholangiography (IOC) is selectively employed in 30-50% of procedures, particularly when anatomy is unclear, to map the biliary tree and avert inadvertent injury, though routine use is debated due to cost and false positives. Bailout strategies, such as subtotal cholecystectomy, may be invoked if CVS cannot be safely achieved.[92][100]Other intraoperative complications
During laparoscopic cholecystectomy, hemorrhage represents one of the most frequent intraoperative complications, primarily arising from injury to the cystic artery or bleeding in the liver bed. The cystic artery, which supplies the gallbladder, is particularly vulnerable during dissection in Calot's triangle, while liver bed bleeding often occurs due to the friable parenchyma in cases of inflammation or cirrhosis. Management typically involves immediate application of hemostatic clips or ligatures to secure the cystic artery, electrocautery for smaller vessels, or temporary packing of the liver bed to achieve hemostasis, with conversion to open surgery if bleeding is uncontrolled. In open cholecystectomy, the incidence of significant hemorrhage is higher, ranging from 3% to 5%, compared to 1% to 2% in laparoscopic approaches overall for intraoperative vascular events.[103][104][103] Visceral injuries, such as bowel perforation, are less common but serious intraoperative risks, occurring during trocar insertion, adhesiolysis, or retraction. The incidence of bowel injury in laparoscopic cholecystectomy is approximately 0.1% to 0.5%, with small bowel involvement in the majority of cases. These injuries are often managed laparoscopically through primary repair or suturing if recognized intraoperatively, though conversion to open laparotomy is required in up to 69% of unrecognized or complex cases to facilitate thorough assessment and repair. Mitigation strategies emphasize meticulous adhesiolysis under direct laparoscopic vision and careful trocar placement to minimize such risks.[105] Anesthetic-related complications, including carbon dioxide (CO2) embolism from pneumoperitoneum insufflation, are rare but potentially life-threatening. CO2 embolism occurs when gas enters the venous system, leading to hemodynamic instability, with an incidence of less than 0.1% in laparoscopic cholecystectomy procedures. Prompt recognition via end-tidal CO2 monitoring and management through immediate desufflation, Trendelenburg positioning, and supportive ventilation are critical to prevent paradoxical embolism or cardiac arrest. Overall, intraoperative complications like these have an aggregate incidence of 1% to 2% in standard laparoscopic cases, often co-occurring with biliary injuries but addressed through vigilant surgical technique and intraoperative monitoring.[106][107][4] Gallbladder perforation with spillage of gallstones is a common occurrence in laparoscopic cholecystectomy, reported in 10-30% of cases, particularly in inflamed gallbladders. While most spilled stones remain asymptomatic, clinical complications such as intra-abdominal abscesses, fistulas, or intestinal obstruction arise in 0.1-6% of patients (commonly cited as 0.1-0.3% in large series), often manifesting months to years later.Postoperative complications
Postoperative complications following cholecystectomy can arise during the recovery phase and may include bile leaks, infections, and other systemic issues, potentially leading to prolonged hospital stays or readmissions. These complications are generally less frequent with laparoscopic approaches compared to open surgery, but vigilant monitoring is essential to ensure timely intervention. A large 2025 international prospective cohort study (AMBROSE), analyzing data from 21,706 patients across 57 countries, reported a 30-day postoperative complication rate of 8.0% following cholecystectomy, with mortality in 0.4% (83 patients). Major complications (Clavien-Dindo III+) occurred in 2.6%. Rates varied significantly by setting: 4.4% in elective, 9.6% in delayed, and 14.6% in emergency cases. Bile leaks (Strasberg grade A) were reported in 1.3% (278 patients), and severe bile duct injuries (Strasberg grades B–E) in 0.2% (48 patients). Bleeding occurred in 0.8%, and among day-case procedures, complications arose in 3.9%. The study identified patient age, ASA physical status, surgical setting, operative approach, and Nassar operative difficulty grade as key predictors of complications. These figures align with laparoscopic cholecystectomy being the predominant approach in modern practice and highlight higher risks in emergency and complex cases.[108] Bile leaks occur in approximately 0.3% to 2.7% of cases after laparoscopic cholecystectomy, often originating from the cystic duct stump, accessory ducts, or as a consequence of unrecognized biliary injury. Diagnosis typically involves assessment of drain output for bilious fluid, elevated bilirubin levels, and imaging such as computed tomography (CT) or hepatobiliary scintigraphy if symptoms like abdominal pain or fever persist. Management usually entails endoscopic retrograde cholangiopancreatography (ERCP) with stent placement to facilitate bile duct drainage, achieving success rates exceeding 90% in most patients. Infections represent a common postoperative concern, with surgical site infections affecting 2% to 5% of laparoscopic cases and up to 10% of open procedures. Other infections, such as pneumonia or urinary tract infections, may occur due to immobility or instrumentation, though their incidence is reduced by 50% or more with perioperative antibiotic prophylaxis in high-risk patients. Prophylactic antibiotics, administered as a single dose preoperatively, are recommended for those with acute cholecystitis or other risk factors to minimize these events. Additional complications include post-cholecystectomy syndrome, affecting 5% to 10% of patients, which manifests as persistent abdominal pain, diarrhea due to altered bile acid metabolism, or dyspepsia. Deep vein thrombosis (DVT) is rare, with an incidence of about 0.5%, particularly in prolonged procedures or patients with comorbidities, and is mitigated by early mobilization and thromboprophylaxis. Typical postoperative discomfort includes abdominal soreness, shoulder pain from gas insufflation, and incision discomfort, but leg pain (especially in the calf, thigh, or groin) is not normal during recovery and may indicate DVT, particularly if accompanied by swelling, redness, or tenderness. Patients experiencing such leg pain should seek immediate medical attention.[109][110][111] Readmissions within 30 days occur in 5% to 10% of cases, frequently attributed to uncontrolled pain, nausea, or dehydration rather than surgical issues. Routine postoperative monitoring involves laboratory tests, including liver function tests and complete blood count on postoperative day 1, to detect early signs of infection or biliary complications. Imaging, such as ultrasound or CT, is reserved for patients with persistent symptoms like fever, jaundice, or increasing pain, enabling prompt diagnosis and intervention.Postoperative Management
Immediate postoperative care
Following laparoscopic cholecystectomy, patients are transferred to the post-anesthesia care unit (PACU) for initial recovery, where vital signs including blood pressure, heart rate, respiratory rate, oxygen saturation, and temperature are continuously monitored to ensure stability and detect early signs of complications such as bleeding or respiratory distress. Airway patency is promptly assessed, and patients are observed until they meet criteria for transfer to a surgical ward or discharge.[112] Pain management in the immediate postoperative period employs a multimodal approach to minimize opioid use and facilitate recovery, including scheduled acetaminophen combined with nonsteroidal anti-inflammatory drugs (NSAIDs) or cyclooxygenase-2 (COX-2) inhibitors, alongside local anesthetic infiltration at the surgical sites.[113] Patient-controlled analgesia (PCA) with opioids may be used initially if needed, but transition to oral analgesics occurs rapidly as pain subsides, with shoulder pain from residual carbon dioxide often resolving within 24 hours.[2] Dietary progression begins with clear liquids in the PACU or shortly after, advancing to a regular diet as tolerated within the first 24 hours to promote gastrointestinal motility while monitoring for postoperative ileus, characterized by nausea, vomiting, or absent bowel sounds.[12] Early oral intake is encouraged in uncomplicated cases to reduce hospital stay and support enhanced recovery protocols.[12] Early mobilization is initiated within hours of surgery, with patients encouraged to ambulate to prevent deep vein thrombosis (DVT) and pulmonary complications, supplemented by incentive spirometry while awake to maintain lung expansion.[2] This approach aligns with enhanced recovery after surgery (ERAS) principles, reducing the risk of thromboembolic events without routine need for pharmacologic prophylaxis in low-risk patients.[62] For uncomplicated laparoscopic cholecystectomy, same-day discharge is feasible in the majority of elective cases, with criteria including stable vital signs, adequate pain control on oral medications, tolerance of oral fluids without nausea, ability to ambulate independently, and absence of fever or other concerning symptoms.[12] Inpatient observation for 23 hours may be required for higher-risk patients, such as those over 50 years or with acute cholecystitis, to ensure safety.[12] Follow-up typically involves an outpatient clinic visit 1-2 weeks postoperatively for wound inspection, assessment of recovery, and discussion of any persistent symptoms, allowing early detection of issues like port-site infections.[2] Patients are advised to monitor for signs warranting immediate medical attention, such as fever, increasing abdominal pain, or symptoms suggestive of deep vein thrombosis (DVT), including unilateral leg pain (particularly in the calf, thigh, or groin), swelling, redness, or tenderness in the leg. Leg pain is not a typical feature of normal postoperative recovery, which more commonly involves abdominal soreness, shoulder pain from residual carbon dioxide gas, and discomfort at the incision sites; such leg symptoms require prompt medical evaluation.[110][114] Patients should refrain from driving while taking opioid or narcotic pain medications due to potential impairment of reaction time and cognitive function. Driving may be resumed only when the patient can perform an emergency stop without pain or discomfort, exhibits normal reaction time, and is no longer requiring strong pain medications. For laparoscopic cholecystectomy (the most common approach), resumption is typically possible within a few days to 1-2 weeks, though this varies by individual recovery, pain levels, and overall condition. Patients should consult their surgeon for personalized advice and review their car insurance policy for any specific restrictions or requirements.[6][7][115]Recovery Timeline
Recovery time after cholecystectomy varies depending on the surgical approach (laparoscopic or open) and whether the procedure was elective or emergent (e.g., for acute cholecystitis). Laparoscopic cholecystectomy is the most common and generally allows faster recovery.- Laparoscopic cholecystectomy (minimally invasive): Patients are often discharged the same day or after an overnight stay in uncomplicated cases. In emergency situations or with acute inflammation, a 1-2 day hospital stay is common. Most people return to light activities, desk work, or normal routines within 1-2 weeks. Full recovery, including return to strenuous exercise or heavy lifting, typically takes about 2 weeks, though some may need up to 4-6 weeks to regain full energy. Shoulder pain from residual carbon dioxide gas usually resolves within a few days.
- Open cholecystectomy (larger incision, used in complicated or converted cases): Requires a hospital stay of 2-3 days, sometimes longer if complications arise. Full recovery at home generally takes 4-6 weeks, and up to 6-8 weeks before resuming normal activities, including work and exercise. The larger incision leads to more pain and slower healing.
Common Experiences During Recovery
- Pain and discomfort: Managed with medications; includes abdominal soreness and temporary shoulder pain from gas.
- Fatigue: Common for the first 1-2 weeks; rest is recommended.
- Dietary changes: Start with clear liquids, advance to low-fat foods. Temporary diarrhea or loose stools may occur in some patients (often resolves in 2-4 weeks, though it can persist longer in cases of postcholecystectomy syndrome).
- Activity: Walk early to prevent complications. Avoid heavy lifting until cleared by surgeon.
Long-term prognosis
Cholecystectomy achieves high rates of long-term symptom relief in patients with gallstone disease, with approximately 90-95% experiencing resolution of biliary pain and related symptoms. A meta-analysis of symptomatic patients reported complete symptom relief in 92% following the procedure.[116] This success is attributed to the elimination of the gallbladder as a site for stone formation and inflammation, leading to sustained alleviation of episodic pain in the majority of cases. Recurrence of gallstones is rare after complete cholecystectomy, occurring in less than 1% of patients due to the absence of the gallbladder. However, post-cholecystectomy syndrome, characterized by persistent or new symptoms such as dyspepsia and diarrhea, affects 10-20% of patients, often linked to altered bile flow dynamics.[5] Overall mortality associated with the procedure is low at under 0.5% in elective cases, though it rises to 1-2% in emergency settings due to factors like acute inflammation or patient comorbidities. Postoperative complications, such as biliary injuries, can adversely influence long-term prognosis by necessitating additional interventions. Quality of life generally improves post-cholecystectomy, as evidenced by enhanced scores on the SF-36 health survey across physical and mental domains. However, a subset of patients develops bile acid malabsorption, contributing to chronic diarrhea and reduced well-being, with chronic diarrhea incidence up to 20%.[117] Patients may resume moderate alcohol consumption after full recovery, typically 4-6 weeks following laparoscopic cholecystectomy, as the liver metabolizes alcohol independently of the gallbladder. However, the absence of the gallbladder results in continuous bile flow, which can exacerbate postcholecystectomy symptoms such as diarrhea, bloating, gas, or nausea in some individuals, potentially reducing alcohol tolerance. It is advisable to begin with small amounts and monitor individual reactions.[118][119] For individuals with comorbidities, annual follow-up is recommended, including monitoring of liver function tests to detect any late-onset issues like bile duct strictures or metabolic changes. In managing postcholecystectomy syndrome, particularly persistent diarrhea or steatorrhea from continuous bile drip and potential fat malabsorption, some integrative approaches include over-the-counter digestive enzyme supplements (containing lipase, protease, and amylase, sometimes with added ox bile). These may aid in breaking down fats and reducing associated symptoms such as greasy stools, bloating, gas, and loose stools after meals. Evidence is primarily from small studies, clinical observations, and anecdotal reports rather than large randomized trials; they do not address the underlying bile acid malabsorption (which is better managed with bile acid sequestrants like cholestyramine) or dissolve gallstones. Use should be guided by a healthcare provider to avoid interactions or unnecessary supplementation in those without deficiency.Substance use in postoperative recovery
Patients should avoid alcohol and recreational substances, including cannabis (marijuana) in all forms (smoking, vaping, edibles), during the immediate recovery phase—typically for at least 1-2 weeks after laparoscopic cholecystectomy or longer after open surgery, or until cleared by the surgeon and no longer taking prescription pain medications. Reasons include:- Potential interactions with residual anesthesia effects (up to 24 hours or more) and opioid or sedative pain medications, increasing risks of excessive drowsiness, respiratory depression, or impaired judgment.
- Smoking or vaping cannabis can irritate the airway, cause coughing that stresses abdominal incisions, raises blood pressure, and increases bleeding risk.
- General impairment of wound healing, immune function, or recovery in the early period.